logo
Homeowners scramble as insurers quietly pull out of wildfire-prone areas: 'It is a problem for everybody'

Homeowners scramble as insurers quietly pull out of wildfire-prone areas: 'It is a problem for everybody'

Yahoo4 days ago

Homeowners in Idaho are scrambling to find affordable insurance after many companies have reduced or stopped coverage in the state.
As the Idaho Statesman reported, wildfires in Idaho have increased in size and severity in recent years because of rising global temperatures. While some homeowners have adapted by adding fireproof features to their homes and removing plants that are susceptible to burning, some insurance companies feel it's too risky to continue operating.
Insurers told Dean Cameron, the director of the state's Department of Insurance, that Idaho is "just one firestorm away from this taking out, wiping out a whole community."
Because of this, several insurance companies have stopped writing new policies, limited coverage to properties that aren't in fire-prone areas, and increased premiums to offset potential losses.
This year, 25 of Idaho's 91 property insurance companies discontinued some or all coverage because of wildfire risks. Any remaining coverage has gone up substantially, with insurance premiums rising by 46% from 2021 to 2023 in the state, according to a report by insurance agency Policygenius.
"There is a general belief that this is just a rich-people-that-live-in-wildland-interface problem."
"That's not the case," Cameron told the Idaho Statesman. "It is a problem for everybody."
Higher insurance premiums affect current and future homeowners; if costs go up too much, people may struggle to pay other bills or even be forced to obtain coverage through state-run programs that are meant to be a last resort, since they typically only provide basic protection.
For prospective homebuyers, limited availability of insurance can make it difficult to buy a home, since lenders require proof of insurance before approving loans.
The insurance industry is experiencing volatility across the United States, with numerous companies having to raise prices to offset damages from increasingly frequent storms. Burning dirty fuels such as oil and gas has put more heat-trapping gases in the atmosphere, leading to higher temperatures, the perfect conditions for extreme weather.
Do you think your house could withstand a hurricane?
No way
Maybe a weak one
I'm not sure
It definitely could
Click your choice to see results and speak your mind.
States such as Florida, Texas, Louisiana, and California are among the most vulnerable to natural disasters, and therefore, a chaotic and unstable insurance market. But even in the Upper Midwest, which isn't normally associated with severe weather events, home insurance premiums have risen by nearly 40% over the past seven years.
The shifting climate doesn't discriminate, and unfortunately, that means millions of people are dealing with skyrocketing insurance costs.
Luckily, the Statesman reported that Idaho is "better positioned" than other Western states to handle the insurance crisis.
While the Department of Insurance understands companies still need to make a profit, it's hosted public demonstrations to show homeowners how to make their properties fire-resistant to lower the risks of extensive damage or loss.
These "home hardening" initiatives, which include removing flammable vegetation and installing fire-resistant materials, have helped many homeowners keep their insurance, as a YouTube video uploaded by KTVB detailed.
Earlier this year, Cameron pushed for a measure to assist homeowners with funds to upgrade their properties and protect them from wildfires, but it did not pass.
If you want to make your home fire-resistant without spending too much, you can always use a fire-retardant paint on your home's exterior and fire-retardant fabric spray on upholstery that will at least make fabrics harder to ignite, as Life Hacker recommended.
Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

World Bank restores funding to Uganda despite controversial anti-gay law
World Bank restores funding to Uganda despite controversial anti-gay law

Business Insider

time38 minutes ago

  • Business Insider

World Bank restores funding to Uganda despite controversial anti-gay law

The World Bank has restored funding to Uganda nearly two years after suspending new financing in response to the country's Anti-Homosexuality Act (AHA). The World Bank has resumed funding to Uganda after a two-year suspension instigated by the Anti-Homosexuality Act (AHA). The Bank justified resumption through effective mitigation measures within ongoing Ugandan projects to limit potential adverse impacts. While Uganda's AHA remains unchanged, the decision signals shifting geopolitical dynamics by international financial institutions. The World bank in 2023, suspended funding to Uganda after the country's parliament passed the Anti-Homosexuality Act (AHA), saying the law contradicted its values. The legislation sparked international condemnation for imposing severe penalties on LGBTQ+ individuals, including life imprisonment and, in some cases, the death penalty. According to Reuters, the World Bank said it had developed a working relationship with Ugandan authorities to implement strong measures aimed at mitigating potential harm resulting from the law. " We have now determined the mitigation measures rolled out over the last several months in all ongoing projects in Uganda to be satisfactory," " Consequently, the Bank has prepared three new projects in sectors with significant development needs – social protection, education, and forced displacement/refugees, which have been approved by the Board." said a Bank spokesperson, who requested anonymity. The decision to resume funding signals a shift in the Bank's engagement strategy with Uganda and raises broader questions about how global institutions navigate the tension between promoting human rights and maintaining development partnerships. While there has been no indication of changes to Uganda's legal position on LGBTQ+ rights, the World Bank's renewed support may reflect wider geopolitical and economic considerations in the region. How the world reacted to Uganda's Anti-Gay Law Uganda's Anti-Homosexuality Act (AHA), signed into law in May 2023, imposed sweeping criminal penalties for same-sex relationships, including life imprisonment and, in cases of so-called 'aggravated homosexuality,' the death penalty. The law drew swift and widespread condemnation from Western governments, human rights organizations, and international institutions, and was widely regarded as one of the harshest anti-LGBTQ+ laws in the world. Beyond the World Bank's suspension of funding, several Western governments issued strong rebukes and implemented measures affecting Uganda's international standing. The United States led the diplomatic response, with the Biden administration describing the law as 'a tragic violation of universal human rights.' In turn, Washington imposed travel restrictions on Ugandan officials believed to be involved in the legislation and initiated a review of its financial assistance to the country. The European Union also condemned the law, emphasizing its incompatibility with international human rights norms and warning that it would reassess its relationship with Uganda. Similarly, the UN High Commissioner for Human Rights called the legislation 'shocking' and 'discriminatory,' urging its immediate repeal. Outside of official government action, Western-based human rights organizations, NGOs, and civil society groups amplified the global outcry. Advocacy campaigns were launched to pressure the Ugandan government, while some multinational corporations voiced concern about the law's potential impact on employees and business operations in the country. Despite this international backlash, Ugandan officials have welcomed the recent restoration of World Bank funding, portraying it as an endorsement of the country's sovereignty and development agenda.

Asia-Pacific Pharmaceutical CMO Market Share Analysis, Trends and Growth Forecasts to 2030 Featuring Catalent, Recipharm, Jubilant Life Sciences and More
Asia-Pacific Pharmaceutical CMO Market Share Analysis, Trends and Growth Forecasts to 2030 Featuring Catalent, Recipharm, Jubilant Life Sciences and More

Yahoo

time2 hours ago

  • Yahoo

Asia-Pacific Pharmaceutical CMO Market Share Analysis, Trends and Growth Forecasts to 2030 Featuring Catalent, Recipharm, Jubilant Life Sciences and More

Key industry drivers include cost advantages in China, 100% FDI in India, and demand for injectable drugs in cancer research Dublin, June 06, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Pharmaceutical Contract Manufacturing Organization - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025-2030)" report has been added to offering. The Asia-Pacific Pharmaceutical Contract Manufacturing Organization (CMO) Market is poised for remarkable growth, advancing from an estimated USD 59.97 billion in 2025 to a forecasted USD 91.18 billion by 2030, reflecting a robust compound annual growth rate (CAGR) of 8.74% during this period. China's competitive edge in the CMO market is underscored by its low labor costs, tax incentives, and advantageous currency valuation, which enable pharmaceutical companies to significantly reduce manufacturing expenses. The country benefits from a workforce trained in Western standards, who are returning amid stringent immigration policies abroad. These dynamics, along with government support, have positioned China as a major pharmaceutical manufacturing hub. India, too, is capitalizing on the burgeoning CMO market, attracting Japanese pharmaceutical investments through favorable foreign direct investment policies. This strategic alignment is fostering partnerships that significantly bolster the domestic manufacturing landscape. Japan's CMO sector, although nascent, has observed a substantial 30% growth following regulatory changes that distinguish manufacturing from sales. Leading players include Bushu Pharmaceuticals and CMIC. Australia's pharmaceuticals face challenges due to pricing and reimbursement volatility, yet its geographical location near South Asian markets enhances its export potential. The COVID-19 pandemic, having originated in Wuhan, a vital pharmaceutical center, has affected global supply chains. This disruption necessitates strategic responses to inventory management, as China provides essential raw materials. Injectable Dose Formulations Lead Growth The demand for injectable drugs, driven by the need for rapid acting oncology treatments, underscores a significant opportunity within the market. These formulations promise higher returns due to therapeutic efficiency and swift action. Prolific late-stage clinical trials, chiefly in cancer therapies, are poised to amplify market growth, with anti-cancer drugs comprising nearly half of the developmental pipeline. Outsourcing of biologic formulations to CMOs is prevalent, as major pharmaceutical entities concentrate on the discovery and development of new drug modalities. India's Impactful CMO Market Share India leverages its vast manpower and regulatory approval to attract multinational pharmaceutical enterprises, enhancing its global footprint in drug manufacturing. Recent policies allowing certain drug studies without late-stage clinical trials lead to considerable cost savings, fortifying India's appeal for pharmaceutical production. The impact of the COVID-19 outbreak on India's sector is evident, with increased costs for APIs due to reliance on Chinese production. The APAC pharmaceutical CMO market shows a highly fragmented landscape. Large pharmaceutical firms are increasingly outsourcing production to CMOs, seeking cost efficiency and expertise. Vendors are expanding through strategic collaborations to enhance market share. Recent industry developments include expansions by Jubilant Biosys in India and Boehringer's capacity increase in China. Key Topics Covered1 INTRODUCTION1.1 Study Assumptions and Market Definition1.2 Scope of the Study2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY4 MARKET DYNAMICS4.1 Market Overview4.2 Industry Attractiveness - Porter's Five Forces Analysis4.3 Industry Value Chain Analysis4.4 Industry Policies4.5 Market Drivers4.5.1 Increasing Outsourcing Volume by Pharmaceutical Companies4.6 Market Restraints4.6.1 Increasing Lead Time and Logistics Costs4.6.2 Stringent Regulatory Requirements4.6.3 Capacity Utilization Issues Affecting the Profitability of CMOs4.7 Assessment of Impact of COVID-19 on the market5 TECHNOLOGY SNAPSHOT6 MARKET SEGMENTATION6.1 Service Type6.1.1 Active Pharmaceutical Ingredient (API) Manufacturing6.1.1.1 Small Molecule6.1.1.2 Large Molecule6.1.1.3 High Potency API (HPAPI)6.1.2 Finished Dosage Formulation (FDF) Development and Manufacturing6.1.2.1 Solid Dose Formulation6.1.2.2 Liquid Dose Formulation6.1.2.3 Injectable Dose Formulation6.1.3 Secondary Packaging6.2 Country6.2.1 China6.2.2 India6.2.3 Japan6.2.4 Australia6.2.5 Rest of Asia-Pacific7 COMPETITIVE LANDSCAPE7.1 Company Profiles7.1.1 Catalent Inc.7.1.2 Recipharm AB7.1.3 Jubilant Life Sciences Ltd.7.1.4 Thermo Fisher Scientific Inc. (Patheon Inc.)7.1.5 Boehringer Ingelheim Group7.1.6 Pfizer CentreSource (Pfizer Inc.)7.1.7 Aenova Group7.1.8 Famar SA7.1.9 Baxter Biopharma Solutions(Baxter International Inc.)7.1.10 Lonza Group8 INVESTMENT ANALYSIS9 FUTURE OF THE MARKET For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store